JP2024542881A5 - - Google Patents
Info
- Publication number
- JP2024542881A5 JP2024542881A5 JP2024529786A JP2024529786A JP2024542881A5 JP 2024542881 A5 JP2024542881 A5 JP 2024542881A5 JP 2024529786 A JP2024529786 A JP 2024529786A JP 2024529786 A JP2024529786 A JP 2024529786A JP 2024542881 A5 JP2024542881 A5 JP 2024542881A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- halo
- cycloalkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163281133P | 2021-11-19 | 2021-11-19 | |
| US63/281,133 | 2021-11-19 | ||
| PCT/US2022/050221 WO2023091554A1 (en) | 2021-11-19 | 2022-11-17 | Novel heteroaryl-urea compounds as kv7.2 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542881A JP2024542881A (ja) | 2024-11-18 |
| JP2024542881A5 true JP2024542881A5 (cg-RX-API-DMAC7.html) | 2025-11-26 |
Family
ID=84887415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529786A Pending JP2024542881A (ja) | 2021-11-19 | 2022-11-17 | Ｋｖ７．２阻害剤としての新規ヘテロアリール－尿素化合物 |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121511239A (zh) * | 2023-07-12 | 2026-02-10 | 豪夫迈·罗氏有限公司 | Sarm1抑制剂 |
| WO2025252599A1 (en) * | 2024-06-04 | 2025-12-11 | Angelini Pharma S.P.A. | Activating compounds of potassium channels kv7.2/kv7.3 |
| WO2025252600A1 (en) * | 2024-06-04 | 2025-12-11 | Angelini Pharma S.P.A. | Activating compounds of potassium channels kv7.2/kv7.3 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4200259A1 (de) | 1992-01-08 | 1993-07-15 | Asta Medica Ag | Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung |
| KR102709682B1 (ko) * | 2018-03-28 | 2024-09-25 | 한림제약(주) | 2-시아노피리미딘-4-일 카르바메이트 혹은 유레아 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| HRP20240012T1 (hr) | 2019-02-06 | 2024-03-29 | Eli Lilly And Company | Derivati 1-((2-(2,2,2-trifluoroetoksi)piridin-4-il)metil)uree kao kcnq potencijatori |
| US20220160705A1 (en) * | 2019-03-20 | 2022-05-26 | Cornell University | Methods for controlling prostaglandin-mediated biological processes |
| CN115461327A (zh) * | 2020-04-29 | 2022-12-09 | 爱杜西亚药品有限公司 | 螺脲衍生物 |
| AU2021295422A1 (en) * | 2020-06-25 | 2023-02-23 | Idorsia Pharmaceuticals Ltd | Cyclobutyl-urea derivatives |
-
2022
- 2022-11-17 JP JP2024529786A patent/JP2024542881A/ja active Pending
- 2022-11-17 US US18/710,702 patent/US20250074901A1/en active Pending
- 2022-11-17 CN CN202280077100.7A patent/CN118525003A/zh active Pending
- 2022-11-17 AU AU2022390453A patent/AU2022390453B2/en active Active
- 2022-11-17 IL IL312719A patent/IL312719A/en unknown
- 2022-11-17 CR CR20240203A patent/CR20240203A/es unknown
- 2022-11-17 WO PCT/US2022/050221 patent/WO2023091554A1/en not_active Ceased
- 2022-11-17 PE PE2024001093A patent/PE20242216A1/es unknown
- 2022-11-17 EP EP22839542.2A patent/EP4433453A1/en active Pending
- 2022-11-17 MX MX2024006027A patent/MX2024006027A/es unknown
- 2022-11-17 KR KR1020247017893A patent/KR20240109608A/ko active Pending
- 2022-11-17 CA CA3239079A patent/CA3239079A1/en active Pending
-
2024
- 2024-05-16 CL CL2024001481A patent/CL2024001481A1/es unknown
- 2024-06-07 CO CONC2024/0007202A patent/CO2024007202A2/es unknown